218 related articles for article (PubMed ID: 30255371)
1. Diagnostic imaging of gastrointestinal neuroendocrine tumours (GI-NETs): relationship between MDCT features and 2010 WHO classification.
Grazzini G; Danti G; Cozzi D; Lanzetta MM; Addeo G; Falchini M; Masserelli A; Pradella S; Miele V
Radiol Med; 2019 Feb; 124(2):94-102. PubMed ID: 30255371
[TBL] [Abstract][Full Text] [Related]
2. CT evaluation of gastroenteric neuroendocrine tumors: relationship between ct features and the pathologic classification.
Feng ST; Luo Y; Chan T; Peng Z; Chen J; Chen M; Li ZP
AJR Am J Roentgenol; 2014 Sep; 203(3):W260-6. PubMed ID: 25148182
[TBL] [Abstract][Full Text] [Related]
3. A simple morphological classification to estimate the malignant potential of pancreatic neuroendocrine tumors.
Oba A; Kudo A; Akahoshi K; Kishino M; Akashi T; Katsuta E; Iwao Y; Ono H; Mitsunori Y; Ban D; Tanaka S; Eishi Y; Tateishi U; Tanabe M
J Gastroenterol; 2017 Oct; 52(10):1140-1146. PubMed ID: 28488114
[TBL] [Abstract][Full Text] [Related]
4. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
Kim JY; Hong SM
Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
[TBL] [Abstract][Full Text] [Related]
5. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
[TBL] [Abstract][Full Text] [Related]
6. Incidental neuroendocrine tumors of the pancreas: MDCT findings and features of malignancy.
Gallotti A; Johnston RP; Bonaffini PA; Ingkakul T; Deshpande V; Fernández-del Castillo C; Sahani DV
AJR Am J Roentgenol; 2013 Feb; 200(2):355-62. PubMed ID: 23345357
[TBL] [Abstract][Full Text] [Related]
7. Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features.
Rodríguez Laval V; Pavel M; Steffen IG; Baur AD; Dilz LM; Fischer C; Detjen K; Prasad V; Pascher A; Geisel D; Denecke T
Neuroendocrinology; 2018; 106(2):139-147. PubMed ID: 28384635
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging.
Danti G; Flammia F; Matteuzzi B; Cozzi D; Berti V; Grazzini G; Pradella S; Recchia L; Brunese L; Miele V
Radiol Med; 2021 Dec; 126(12):1497-1507. PubMed ID: 34427861
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
Belousova E; Karmazanovsky G; Kriger A; Kalinin D; Mannelli L; Glotov A; Karelskaya N; Paklina O; Kaldarov A
Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421
[TBL] [Abstract][Full Text] [Related]
10. Clusterin expression in gastrointestinal neuroendocrine tumours is highly correlated with location and is helpful in determining the origin of liver metastases.
Mourra N; Scriva A; Mansiaux Y; Gozlan S; Bennis M; Balaton A
Histopathology; 2014 Nov; 65(5):642-50. PubMed ID: 24807631
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
12. Radiological features and metastatic patterns of thymic neuroendocrine tumours.
Araki T; Sholl LM; Hatabu H; Nishino M
Clin Radiol; 2018 May; 73(5):479-484. PubMed ID: 29310810
[TBL] [Abstract][Full Text] [Related]
13. [Endoscopic ultrasonography in patients suspected of neuroendocrine tumours].
Ainsworth AP; Fristrup CW; Mortensen MB; Nielsen HO
Ugeskr Laeger; 2008 May; 170(22):1938-40. PubMed ID: 18513479
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological classification and prognostic factors of gastrointestinal neuroendocrine neoplasms: an analysis of 119 cases].
Ma X; Zhao W; Zhuang C; Wang X; Tu L; Wang M; Sun Y; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):997-1001. PubMed ID: 28900989
[TBL] [Abstract][Full Text] [Related]
15. Outcome and CT differentiation of gallbladder neuroendocrine tumours from adenocarcinomas.
Kim TH; Kim SH; Lee KB; Han JK
Eur Radiol; 2017 Feb; 27(2):507-517. PubMed ID: 27225621
[TBL] [Abstract][Full Text] [Related]
16. 177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update.
Demirci E; Kabasakal L; Toklu T; Ocak M; Şahin OE; Alan-Selcuk N; Araman A
Nucl Med Commun; 2018 Aug; 39(8):789-796. PubMed ID: 29912750
[TBL] [Abstract][Full Text] [Related]
17. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
Niederle MB; Hackl M; Kaserer K; Niederle B
Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal neuro-endocrine tumors: retrospective study of 36 cases.
Zehani A; Aloui S; Chelly I; Haouet S; Kchir N
Tunis Med; 2017 Jun; 95(6):393-400. PubMed ID: 29512793
[TBL] [Abstract][Full Text] [Related]
19. CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas.
Kim SH; Kim SH; Kim MA; Shin CI; Han JK; Choi BI
Eur Radiol; 2015 Jul; 25(7):1946-57. PubMed ID: 25899412
[TBL] [Abstract][Full Text] [Related]
20. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
